Plus Therapeutics Inc (PSTV) Stock Analysis

Plus Therapeutics Inc (PSTV) is a publicly traded company in the HEALTHCARE sector. It trades at $5.47, carries a market capitalization of $40.06M, a price-to-earnings ratio of 0.27. This page summarizes the public market data, fundamentals, and frequently asked questions for PSTV, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Plus Therapeutics Inc currently has a Neutral sentiment score of 0.02.

About Plus Therapeutics Inc

Plus Therapeutics, Inc. is an innovative clinical-stage pharmaceutical company based in Austin, Texas, specializing in the development of advanced cancer therapies and treatments for serious diseases. The company is at the forefront of creating proprietary drug delivery technologies designed to enhance therapeutic efficacy in oncology. With a strong pipeline of promising drug candidates, Plus Therapeutics is strategically positioned to deliver novel therapeutic options that address substantia...

GNG Research Analysis

GNG Research scores Plus Therapeutics Inc (PSTV) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PSTV.

Frequently Asked Questions

Does PSTV pay dividends?

Plus Therapeutics Inc (PSTV) does not currently pay a regular dividend.

What is PSTV's P/E ratio?

Plus Therapeutics Inc has a price-to-earnings (P/E) ratio of 0.27.

What is PSTV's market cap?

Plus Therapeutics Inc (PSTV) has a market capitalization of $40.06M with a current stock price of $5.47.